Related Experiment Video
Updated: Jul 13, 2025

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure
Simin Meng1, Yi Yu1, Shuo Yu2
1Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University; State Key Laboratory of Transvascular Implantation Devices; Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
Insights
Heart failure (HF) involves energy metabolism disruptions. This review explores cardiac metabolic remodeling and new drug therapies targeting metabolism to restore heart function.
Area of Science:
- Cardiology
- Metabolic Medicine
- Biochemistry
Background:
- The heart requires significant energy, making its metabolism crucial for function.
- Heart failure (HF) arises from disruptions in cardiac energy metabolism.
- Current HF treatments focus on neurohormonal and hemodynamic factors, highlighting a need for metabolic targets.
Purpose of the Study:
- To review cardiac metabolic remodeling in both healthy and failing hearts.
- To discuss the roles of various substrates like fatty acids, glucose, ketone bodies, and branched-chain amino acids in cardiac metabolism.
- To explore recent pharmacological interventions for HF targeting metabolic pathways.
Main Methods:
- Literature review of physiological and pathological cardiac metabolism.
- Analysis of studies on substrate utilization in the heart.
- Synthesis of findings from basic research, preclinical, and clinical studies on metabolic therapies for HF.
Main Results:
- Cardiac metabolism significantly shifts in heart failure, altering substrate preference and efficiency.
- Dysregulation of fatty acid, glucose, ketone body, and branched-chain amino acid metabolism is implicated in HF.
- Pharmacological targeting of cardiac metabolism shows promise in preclinical and clinical studies.
Conclusions:
- Cardiac metabolic remodeling is a key factor in heart failure development and progression.
- Metabolic modulators represent a promising therapeutic avenue for heart failure.
- Further research into metabolic interventions is warranted to improve HF treatment.
Abstract:
The heart is the most energy-demanding organ throughout the whole body. Perturbations or failure in energy metabolism contributes to heart failure (HF), which represents the advanced stage of various heart diseases. The poor prognosis and huge economic burden associated with HF underscore the high unmet need to explore novel therapies targeting metabolic modulators beyond conventional approaches focused on neurohormonal and hemodynamic regulators. Emerging evidence suggests that alterations in metabolic substrate reliance, metabolic pathways, metabolic by-products, and energy production collectively regulate the occurrence and progression of HF. In this review, we provide an overview of cardiac metabolic remodeling, encompassing the utilization of free fatty acids, glucose metabolism, ketone bodies, and branched-chain amino acids both in the physiological condition and heart failure. Most importantly, the latest advances in pharmacological interventions are discussed as a promising therapeutic approach to restore cardiac function, drawing insights from recent basic research, preclinical and clinical studies.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure

